The Scientist

» twitter and disease/medicine

Most Recent

image: Speaking of Science

Speaking of Science

By | March 1, 2012

March 2012's selection of notable quotes

6 Comments

image: Suspected Effects of Vitamin D

Suspected Effects of Vitamin D

By | March 1, 2012

March 2012's selection of notable quotes

0 Comments

image: T-Bee

T-Bee

By | March 1, 2012

March 2012's selection of notable quotes

4 Comments

image: The Joint Collector

The Joint Collector

By | March 1, 2012

March 2012's selection of notable quotes

0 Comments

image: Tricky Trials

Tricky Trials

By | March 1, 2012

March 2012's selection of notable quotes

0 Comments

image: Child-Proofing Drugs

Child-Proofing Drugs

By | March 1, 2012

March 2012's selection of notable quotes

6 Comments

image: The Specter of Denialism

The Specter of Denialism

By | March 1, 2012

March 2012's selection of notable quotes

94 Comments

image: Vitamin D on Trial

Vitamin D on Trial

By | March 1, 2012

March 2012's selection of notable quotes

52 Comments

image: Influenza Found in Bats

Influenza Found in Bats

By | February 28, 2012

March 2012's selection of notable quotes

0 Comments

image: Chemo for Stroke?

Chemo for Stroke?

By | February 27, 2012

March 2012's selection of notable quotes

4 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech